Skip to main content
Clinical Trials/PACTR202103587471967
PACTR202103587471967
Completed
Phase 2

Effect of dual task on balance of multiple sclerosis patients

self0 sites30 target enrollmentFebruary 26, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Nervous System Diseases
Sponsor
self
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 26, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
self

Eligibility Criteria

Inclusion Criteria

  • ?Definite diagnosis of relapsing\-remitting multiple sclerosis of ataxic type, fulfilled the Revised McDonald's criteria for diagnosis of multiple sclerosis 2010 (Polman et al., 2011\).
  • ?A score of 1\.0 to 4\.0 on the Expanded Disability Status Scale (EDSS).
  • ?A score of 30 to 26 in Montreal Cognitive Assessment (MoCA).
  • ?Age ranged from 30 – 40 years old.
  • ?All patients were in the remission period.
  • ?Last attack occurred at least in the past two months.
  • ?All Patients were ambulant.
  • ?Patients were medically stable.
  • ?Ability to understand and follow instructions.
  • ?Patients were free from any secondary complications such as contractures or deformities.

Exclusion Criteria

  • Any other neurological deficits or orthopedics abnormalities preventing participation in the study.
  • Patients who have any other inflammatory or infectious diseases, e.g. arthritis.
  • Pregnant female patients.
  • Cardiovascular and Pulmonary diseases.
  • Patients with active or uncontrolled pathologies (i.e. cancer, hypertension).
  • Patients with severe cognitive deficits.
  • Patients with any psychiatric disease.
  • History of seizure.

Outcomes

Primary Outcomes

Not specified

Similar Trials